cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Neuropace Inc
5 own
1 watching
Current Price
$13.4
$-0.1
(-0.74%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
374.33M
52-Week High
52-Week High
18.15000
52-Week Low
52-Week Low
3.79500
Average Volume
Average Volume
0.09M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization374.33M
icon52-Week High18.15000
icon52-Week Low3.79500
iconAverage Volume0.09M
iconDividend Yield--
iconP/E Ratio--
What does the Neuropace Inc do?
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company s RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely. It sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. The company was incorporated in 1997 and is headquartered in Mountain View, California.
Read More
How much money does Neuropace Inc make?
News & Events about Neuropace Inc.
Globe Newswire
1 year ago
MOUNTAIN VIEW, Calif., Feb. 10, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today announced it will report financial results for the fourth quarter and full year of 2022 after ...
Business Wire
1 year ago
NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today announced that the first patient with Lennox-Gastaut Syndrome (LGS) was treated in its feasibility investigational device exemption (IDE) study. LGS is a...
Globe Newswire
1 year ago
MOUNTAIN VIEW, Calif., May 13, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy, today announced it will be participating in the upcoming 2022 RBC Capital Markets Global Healthcare ...
Zolmax
2years ago
NeuroPace (NASDAQ:NPCE Get Rating) released its quarterly earnings data on Thursday. The company reported ($0.44) earnings per share for the quarter, missing the consensus estimate of ($0.33) by ($0.11), MarketWatch Earnings reports. NeuroPace updated its Q1 2022 guidance to EPS and its FY 2022 ...
Ticker Report
2years ago
NeuroPace, Inc. (NASDAQ:NPCE) has been given a consensus recommendation of Buy by the six ratings firms that are presently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The ...
Frequently Asked Questions
Frequently Asked Questions
What is Neuropace Inc share price today?
plus_minus_icon
Can Indians buy Neuropace Inc shares?
plus_minus_icon
How can I buy Neuropace Inc shares from India?
plus_minus_icon
Can Fractional shares of Neuropace Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Neuropace Inc stocks?
plus_minus_icon
What is today’s traded volume of Neuropace Inc?
plus_minus_icon
What is today’s market capitalisation of Neuropace Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Neuropace Inc?
plus_minus_icon
What percentage is Neuropace Inc down from its 52-Week High?
plus_minus_icon
What percentage is Neuropace Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$13.4
$-0.1
(-0.74%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00